Yueran Li Selected Research

Yueran Li Research Topics

5	Neoplasms (Cancer) 01/2021 - 06/2014
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2015 - 06/2014
2	Delayed Hypersensitivity (Hypersensitivity, Type IV) 01/2021 - 01/2020
2	Drug Hypersensitivity (Drug Allergy) 01/2021 - 01/2020
2	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2017
2	Ovarian Neoplasms (Ovarian Cancer) 01/2019 - 01/2018
2	Breast Neoplasms (Breast Cancer) 08/2017 - 01/2017
2	Carcinoma (Carcinomatosis) 10/2015 - 03/2015
1	Immune System Diseases (Immune Disorders) 01/2021
1	Liver Diseases (Liver Disease) 01/2021
1	Hypersensitivity (Allergy) 06/2020
1	Cicatrix (Scar) 01/2020
1	Inflammation (Inflammations) 01/2018

4	Proteins (Proteins, Gene)FDA Link 01/2018 - 06/2014
3	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021 - 06/2020
3	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 03/2015
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2017
1	Chemokine ReceptorsIBA 01/2021
1	LigandsIBA 01/2021
1	KIR ReceptorsIBA 01/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021
1	abacavir (Ziagen)FDA Link 06/2020
1	HLA-B57 antigenIBA 06/2020
1	SOX9 Transcription FactorIBA 01/2019
1	NeurotoxinsIBA 01/2018
1	Nonsense Codon (Nonsense Mutation)IBA 08/2017
1	Indicators and Reagents (Reagents)IBA 08/2017
1	Long Noncoding RNAIBA 01/2017
1	Carrier Proteins (Binding Protein)IBA 01/2017
1	arsenic disulfide (realgar)IBA 10/2015
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 04/2015
1	Immunologic Factors (Immunomodulators)IBA 04/2015
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 04/2015
1	CyclinsIBA 03/2015
1	Retinoblastoma ProteinIBA 03/2015
1	DNA (Deoxyribonucleic Acid)IBA 03/2015
1	PlatinumIBA 03/2015
1	MicroRNAs (MicroRNA)IBA 06/2014
1	Octamer Transcription Factor-1IBA 06/2014

2	Drug Therapy (Chemotherapy) 01/2019 - 01/2018
1	Immunotherapy 01/2021
1	Chemoradiotherapy 03/2015
1	Combination Drug Therapy (Combination Chemotherapy) 03/2015